新興病原体の状況における深層変異スキャンの洞察
Melissa J Call1,2, Matthew E Call1,2, Xinyu Wu1,2
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Biochemical Society transactions
|September 4, 2025
まとめ
ディープ・ミューテーション・スキャニング (DMS) は,SARS-CoV-2のタンパク質機能をマッピングし,薬の開発を支援しています. この高通量シーケンシング方法は,ウイルスの進化と診断と治療への潜在的な影響に関する洞察を明らかにします.
科学分野:
- ウイルス学
- ゲノミクス
- 分子生物学
背景:
- 重症急性呼吸器症候群-コロナウイルス2型 (SARS-CoV-2型) は,世界的な健康上の重大な脅威となっている.
- SARS-CoV-2のタンパク質における変異の機能的影響を理解することは,効果的な対抗策の開発に不可欠です.
研究 の 目的:
- SARS-CoV-2のタンパク質機能の解明におけるディープ・ミューテーション・スキャニング (DMS) の適用をレビューする.
- ウイルスの進化,ACE2結合,免疫回避,薬剤耐性の理解に DMSがどのように影響を与えたかを強調します
- 治療開発とパンデミック対策におけるDMSの関連性を強調する.
主な方法:
- ディープ・ミューテーション・スキャニング (DMS) と 次世代のシーケンシングを組み合わせたものです
- 重要なSARS-CoV-2タンパク質 (スパイク,プロテアゼ,ヌクレオカプシド) の何千ものアミノ酸置換の体系的な評価.
- オーダーメイドの真核細胞 (酵母と哺乳類) ベースのアッセイの開発.
主要な成果:
- DMSは,スパイク (ACE2結合,免疫回避),プロテアゼ (薬物の脱出),およびヌクレオカプシド (診断的含意) を含む,SARS-CoV-2タンパク質の機能的環境をマッピングしました.
- ウイルスのタンパク質機能と潜在的な進化軌跡に影響を与える重要な変異を特定した.
- 薬剤耐性や免疫回避のメカニズムについての洞察を提供した.
結論:
- DMSは,SARS-CoV-2の生物学を理解し,ウイルスの進化を予測するための強力なツールです.
- DMSの発見は治療法と診断法の開発を導く上で極めて重要です.
- この方法論は,将来のパンデミック対策と研究のためのモデルとして機能します.
さらに関連する動画
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
26.0K
関連する概念動画
Modern Molecular Taxonomy
136
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
136
Mutations in Microorganisms
74
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
74
Next-generation Sequencing
92.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.5K
Single Nucleotide Polymorphisms-SNPs
15.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
Viral Mutations
32.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K
